Ethel Santacruz Lezcano

Dr. Ethel Santacruz Lezcano

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista de Nutrição
Verified
Journal Article
Open access
PDF file
RLRodrigo Octavio Burgos Larroza
Rodrigo Octavio Burgos Larroza
ELEthel Santacruz Lezcano
Ethel Santacruz Lezcano
DDDerlis Gustavo Adolfo Duarte-Zoilan
Derlis Gustavo Adolfo Duarte-Zoilan
CTCatherine Turnes
Catherine Turnes
GBGilda Benitez
Gilda Benitez
ENEduardo Augusto Fernandes Nilson
Eduardo Augusto Fernandes Nilson
Objective This study aims to estimate the epidemiological burden of excessive salt intake reduction and achieve the World Health Organization salt reduction target for 2025 in Paraguay, in 2019. Methods We used the Preventable Risk Integrated Model, a comparative risk assessment macro-simulation model, to estimate the averted deaths, disease incidence, and disability-adjusted life years from cardiovascular disease attributable to salt intake in the population of Paraguay for different salt reduction policy scenarios. Results As a result, in Paraguay, excessive salt intake (over 5 g/day) is responsible for approximately 2,656 cardiovascular disease deaths (95% Uncertainty Interval: 1,250-3,765), 4,816 cardiovascular disease cases (95% UI: 2,251-6,947), and 60,529 disability-adjusted life years (95% UI: 27,828-86,258) per year. By reducing salt consumption by 30%, as recommended by the World Health Organization until 2025, approximately 1,188 deaths (95% UI: 520 to 1,820), 2,100 incident cases (95% UI: 923-3,234), and 27,272 disability-adjusted life years (95% UI: 11,999-41,675) from cardiovascular disease could be averted every year. Conclusion In conclusion, the burden of cardiovascular disease attributable to excessive salt intake is significant and salt reduction policies must become a priority in Paraguay.

30 June 2022 in Revista de salud publica del Paraguay
Verified
Journal Article
Open access
PDF file
RBRodrigo Burgos
Rodrigo Burgos
ELEthel Santacruz Lezcano
Ethel Santacruz Lezcano
CTCatherine Turnes
Catherine Turnes
DDDerlis Duarte-Zoilan
Derlis Duarte-Zoilan
CRCalos Ríos-González
Calos Ríos-González
GBGilda Benítez
Gilda Benítez

14 February 2026 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
ABAlberto Barcelo
Alberto Barcelo
RCRoy Wong-Mc Clure
Roy Wong-Mc Clure
FVFelicia Canete Villalba
Felicia Canete Villalba
ELEthel Santacruz Lezcano
Ethel Santacruz Lezcano
NBNoelia Lorena Cañete Borja
Noelia Lorena Cañete Borja
AGArise Galil
Arise Galil
Background: In the Americas, the number of people living with diabetes is expected to rise from 92 million in 2024 to 120 million by 2050. Indigenous populations may experience distinct biological, environmental, and sociocultural risk factors; however, they are often treated as a homogeneous group in epidemiological research, and consolidated evidence on diabetes prevalence across diverse Indigenous populations remains limited. This scoping review examines the prevalence of diabetes among Indigenous populations in the Americas. Methods: Following PRISMA-ScR guidelines, we conducted a systematic scoping review of population-based studies reporting the prevalence of diabetes among Indigenous adult populations in the Americas. Searches were performed in PubMed and Scopus. Collected data included study location, Indigenous group, population characteristics, diagnostic criteria, and test used and reported prevalence estimates. Results: Sixty documents encompassing 73 studies met the inclusion criteria, representing 45,503 individuals from 16 countries between 1975 and 2025. The total number of ethnic groups represented was 111, and 12 studies did not identify a specific ethnic group. Fasting blood glucose (FBG) was the most frequently used diagnostic method, followed by the oral glucose tolerance test (OGTT). Estimates of the prevalence of diabetes varied widely across populations, regions, and time periods. Five studies—from Brazil, Chile, Colombia, Mexico, and Paraguay—did not identify any cases of diabetes. Among studies reporting cases, prevalence ranged from 1 to 70% in North America, 5 to 14% in Central America, and 1 to 29% in South America. Conclusions: The prevalence of diabetes among Indigenous populations varied widely across the region, with substantially higher estimates reported in North America than in Central and South America. The decline in published studies in recent years suggests reduced research attention to this topic. The marked heterogeneity identified in this review underscores the need for standardized measurement approaches to support population-specific strategies aligned with personalized care and precision public health.

15 September 2026 in Psychiatry International
Verified
Journal Article
Open access
PDF file
FVFelicia Canete Villalba
Felicia Canete Villalba
AÁAndrés Ávalos
Andrés Ávalos
ABAlberto Barcelo
Alberto Barcelo
ELEthel Santacruz Lezcano
Ethel Santacruz Lezcano
Mental health problems represent a growing public health burden, particularly in middle-income countries where population-based evidence remains limited. This study aimed to analyze the risk profiles and heterogeneity of symptoms compatible with depression, suicidal ideation, and panic in the adult population of Paraguay. A cross-sectional study was conducted using nationally representative data from the 2022 STEPS survey. The presence of symptoms compatible with depression, panic, and suicidal ideation was assessed using self-reported dichotomous screening questions. Associations with sociodemographic, behavioral, and clinical variables were analyzed using multivariate models, estimating adjusted odds ratios (aOR) with 95% confidence intervals, and the analyses accounted for the complex sampling design. The prevalence of symptoms compatible with depression was 35.8%, panic 22.4%, and suicidal ideation 8.0%. Higher odds were observed in women, younger age groups, urban residents, and individuals reporting daily smoking as well as those with diabetes mellitus. Associations varied across outcomes, reflecting heterogeneous risk patterns. Symptoms compatible with depression, panic, and suicidal ideation are highly prevalent and unequally distributed in the adult population of Paraguay. These findings highlight the need for targeted prevention strategies, early detection, and the integration of mental health into public health and noncommunicable disease policies and management.

24 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ABAlberto Barcelo
Alberto Barcelo
RCRoy Wong-Mc Clure
Roy Wong-Mc Clure
FVFelicia Canete Villalba
Felicia Canete Villalba
ELEthel Santacruz Lezcano
Ethel Santacruz Lezcano
NBNoelia Lorena Cañete Borja
Noelia Lorena Cañete Borja
AGArise Galil
Arise Galil
Background: Diabetes is a growing public health concern worldwide, with an estimated 537 million people affected in 2021. This number is projected to increase by 46% over the next 25 years. In the Americas, the prevalence of diabetes is expected to rise from 84 million in 2021 to 112 million by 2045. Indigenous populations may face unique risk factors, yet there is limited consolidated data on diabetes prevalence within these communities. This systematic review examines the prevalence of diabetes among Indigenous populations in the Americas. Methods: Following PRISMA-ScR guidelines, a systematic search was conducted in Scopus and PubMed. Studies were included if they reported population-based surveys on diabetes prevalence among Indigenous and mestizo adults in the Americas. Data extraction focused on study location, population characteristics, diagnostic criteria, and reported prevalence. Results: A total of 60 documents, representing 73 studies, met the inclusion criteria and covered 45,503 individuals from 16 countries between 1975 and 2025. Mexico contributed the largest number of studies (17), followed by the United States (15), Brazil (10), Canada (7), Chile (6), and Guatemala (5). Most participants were from North America (29,093), followed by Central America (8,144) and South America (6,911). No eligible reports were identified from Caribbean nations, Peru, or Guyana. In total, 111 Indigenous groups were represented. The most frequently used diagnostic method was fasting blood glucose (FBG), applied in 50 studies (75%), followed by the oral glucose tolerance test (OGTT) in 41 studies (61%). The combined prevalence of diabetes among Indigenous and mestizo populations was 12% overall (17% among women and 14% among men). Mean diabetes prevalence was highest in North America (17%), followed by Central America (8.9%) and South America (4.9%). Notably, five studies—from Brazil, Chile, Colombia, Mexico, and Paraguay—reported no cases of diabetes. Conclusions: The prevalence of diabetes among Indigenous populations in the Americas is highly heterogeneous, with considerably higher rates reported in North America compared with Central and South America. Although genetic predisposition may play an important role, environmental and lifestyle factors likely contribute substantially to these differences. The decline in published studies in recent years suggests a reduction in research focus on this topic. Further investigation into modifiable risk factors—such as diet, physical activity, and socioeconomic conditions—is essential to better understand the epidemiology of diabetes, clarify how these determinants interact, and support the development of targeted interventions to reduce risk and address health disparities among Indigenous populations across the region. Keywords: Diabetes, Indigenous populations, Americas, epidemiology, public health, prevalence, systematic review.

6 December 2022 in Medicina Clínica y Social
Verified
Journal Article
Open access
PDF file
ELEthel Santacruz Lezcano
Ethel Santacruz Lezcano
RLRodrigo Octavio Burgos Larroza
Rodrigo Octavio Burgos Larroza
DDDerlis Gustavo Adolfo Duarte-Zoilan
Derlis Gustavo Adolfo Duarte-Zoilan
CSClaudia Sanchez
Claudia Sanchez
GBGilda Benitez
Gilda Benitez
Introducción Para contener la pandemia por (COVID-19) se recurrió al distanciamiento social, cierre de fronteras y cuarentena en el hogar, que pudieron haber repercutido al deterioro de la salud general, un aumento del consumo de alcohol y otras sustancias para contrarrestar la intensidad de la respuesta a estas consecuencias. Objetivo Determinar las características demográficas del consumo de riesgo para alcohol durante la cuarentena estricta por covid-19. Metodología Estudio observacional analítico transversal exploratorio. 16.538 encuestas virtuales realizadas a personas mayores de edad de todo el país entre junio y septiembre del 2020. Se excluyó a 219 encuestados por no cumplir criterios de inclusión. Se determinó el consumo de riesgo mediante puntajes AUDIT-C. Más de 5 puntos para hombres, más de 4 para mujeres. Resultados 16.319 participantes adultos (18-65 años) con una media de 31,9 años (±9,2), con predominio de participación masculina 64,5% (n=10.531). El 39,3% (n=6.408) proveniente de Asunción. El 50,4% (n=8.254) posee educación universitaria completa. Del total de encuestados, el 39,1% (n=6.385) son hombres con consumo de riesgo (más de 5 en el puntaje) y el 22,7% (n=3.712) corresponden a las mujeres con consumo de riesgo (más de 4 en el puntaje). El grupo que presentó mayor consumo fue el de estudios universitarios completos con el 50,6% (n=8.254) Sin embargo, entre las mujeres, el 64% (n=3.712) presentó consumo de riesgo mientras que, en los hombres, el 60,7% (n=6.385). La RP fue de 0,95 IC95 (0,92 – 0,97) Es decir, las mujeres poseen 5% menos de posibilidad de padecer un consumo de riesgo respecto a los hombres. Discusión Durante la cuarentena estricta, el consumo de riesgo crecía conforme el nivel educativo de la población aumentaba. Las mujeres presentaron un consumo de riesgo menor que los hombres. Conocer este comportamiento ayudaría a fortalecer tareas de prevención en los grupos de mayor riesgo.